Physician

Alan E. Gorenberg, MD

According to 2025 Medicare claims, Alan Gorenberg, MD (NPI: 1730115221) practices allergy/immunology in the Riverside-San Bernardino-Ontario, CA market, with the plurality of this provider's patient population coming from San Bernardino, CA. This provider's primary affiliated billing organization is ALAN E. GORENBERG MD, INC. (NPI: 1770514945; TIN: 26-0035678) and primary practice location at 92395-5814. Gorenberg is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Gorenberg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 414 traditional Medicare patients, billed 19,933 HCPCS/CPT codes, and received $231,685 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 983 prescription claims across 213 beneficiaries totaling $3,095,127 in drug costs, led by Takhzyro (Lanadelumab-Flyo). DME data shows 74 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $348,190 to $231,685. In contrast, Part D prescription costs have risen steadily, from $97,996 to $3,095,127. For DME billing, this smaller-volume category moved from a lower plateau to a higher plateau, from $1,390 to $1,148.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	442	24,839	$348,190
2016	453	34,255	$481,019
2017	457	31,265	$391,555
2018	455	33,191	$479,613
2019	459	33,874	$534,912
2020	401	25,957	$339,069
2021	628	28,358	$364,630
2022	428	23,959	$281,007
2023	387	19,277	$229,521
2024	414	19,933	$231,685

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	144	607	$97,996
2016	160	685	$309,107
2017	207	986	$1,044,929
2018	208	932	$319,975
2019	218	865	$357,326
2020	201	989	$1,687,435
2021	191	889	$1,689,247
2022	180	819	$1,515,818
2023	196	940	$1,881,422
2024	213	983	$3,095,127

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	62	$82,570
2016	N/R	23	$72,336
2017	N/R	12	$26,762
2018	N/R	91	$71,272
2019	N/R	160	$70,284
2020	N/R	134	$112,419
2021	N/R	40	$52,187
2022	N/R	26	$35,470
2023	N/R	67	$79,272
2024	N/R	74	$130,033

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	176	229	$65
94060	Test to measure expiratory airflow and volume changes before and after medication administration	112	130	$31
95012	Test to measure the level of nitric oxide gas	124	144	$15
95165	Professional service for preparation and provision of 1 or more antigens	194	5,440	$12
95117	Professional service for multiple injections of allergen	200	2,883	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Takhzyro	Lanadelumab-Flyo	21	588	$1,109,630
Orladeyo	Berotralstat Hydrochloride	14	392	$576,517
Dupixent Syringe	Dupilumab	131	3,630	$482,281
Xolair	Omalizumab	103	3,024	$330,243
Hyqvia	Igg/Hyaluronidase,recombinant	15	450	$208,593

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1575	Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin	N	N/R	12	$64,780
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	17	$64,278
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	16	$729
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	17	$188
E0570	Nebulizer, with compressor	Y	N/R	12	$58

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Alan E. Gorenberg, MD?

Tedicare shows public-source Medicare data for Alan E. Gorenberg, MD (NPI 1730115221), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan E. Gorenberg, MD have ACO affiliation data?

Alan E. Gorenberg, MD is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Alan E. Gorenberg, MD?

Alan E. Gorenberg, MD is linked to ALAN E. GORENBERG MD, INC. (billing NPI 1770514945) in the available physician profile data.

Does Alan E. Gorenberg, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.